Cyclerion Therapeutics
CYCN
CYCN
15 hedge funds and large institutions have $3.59M invested in Cyclerion Therapeutics in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
12% less funds holding
Funds holding: 17 → 15 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
15
Holding in Top 10
1
Calls
$347K
Puts
–
Top Buyers
| 1 | +$56K | |
| 2 | +$6.54K | |
| 3 | +$1.92K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.71K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3 |
Top Sellers
| 1 | -$57.1K | |
| 2 | -$7K | |
| 3 | -$5.7K | |
| 4 |
BlackRock
New York
|
-$2.78K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.76K |